Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$892M |
| 2 |
Merck
MRK
|
+$858M |
| 3 |
Amgen
AMGN
|
+$857M |
| 4 |
Home Depot
HD
|
+$837M |
| 5 |
Cisco
CSCO
|
+$781M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$776M |
| 2 |
United Parcel Service
UPS
|
+$615M |
| 3 |
Qualcomm
QCOM
|
+$587M |
| 4 |
Alibaba
BABA
|
+$555M |
| 5 |
Eaton
ETN
|
+$508M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.68% |
| 2 | Financials | 12.96% |
| 3 | Healthcare | 11.88% |
| 4 | Consumer Discretionary | 11.22% |
| 5 | Industrials | 9.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2676
OptimizeRx
OPRX
$121M
| $1.93M | ﹤0.01% |
39,617
+3,867
| +11% | +$187K |
|
|
GTYH
2677
DELISTED
GTY Technology Holdings, Inc. Common Stock
GTYH
| $1.93M | ﹤0.01% |
302,065
+5,984
| +2% | +$42.1K |
|
2678
Altimmune
ALT
$578M
| $1.93M | ﹤0.01% |
136,494
+14,973
| +12% | +$242K |
|
2679
Dyne Therapeutics
DYN
$4.62B
| $1.9M | ﹤0.01% |
122,492
+40,216
| +49% | +$778K |
|
2680
Peoples Financial Services
PFIS
$706M
| $1.9M | ﹤0.01% |
44,915
+1,433
| +3% | +$59.1K |
|
2681
Korro Bio
KRRO
$154M
| $1.89M | ﹤0.01% |
3,975
+120
| +3% | +$233K |
|
2682
Lakeland Industries
LAKE
$117M
| $1.89M | ﹤0.01% |
67,659
-37,445
| -36% | -$1.16M |
|
2683
Gaotu Techedu
GOTU
$441M
| $1.88M | ﹤0.01% |
55,540
-35
| -0.1% | -$2.85K |
|
|
SPNS
2684
DELISTED
Sapiens International
SPNS
| $1.88M | ﹤0.01% |
58,997
+1,859
| +3% | +$60.3K |
|
2685
Sutro Biopharma
STRO
$406M
| $1.85M | ﹤0.01% |
8,140
+1,117
| +16% | +$265K |
|
2686
United States Lime & Minerals
USLM
$3.24B
| $1.84M | ﹤0.01% |
68,915
+285
| +0.4% | +$7.7K |
|
2687
Lifecore Biomedical
LFCR
$166M
| $1.83M | ﹤0.01% |
172,838
+5,174
| +3% | +$58.2K |
|
2688
Park-Ohio Holdings
PKOH
$584M
| $1.83M | ﹤0.01% |
58,186
+94
| +0.2% | +$3.1K |
|
2689
Citizens
CIA
$241M
| $1.83M | ﹤0.01% |
315,699
+4,037
| +1% | +$24.9K |
|
|
EVLO
2690
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
| $1.82M | ﹤0.01% |
8,520
+1,892
| +29% | +$523K |
|
|
IVC
2691
DELISTED
Invacare Corporation
IVC
| $1.82M | ﹤0.01% |
227,146
-225,302
| -50% | -$2.1M |
|
2692
Frontline
FRO
$8.69B
| $1.82M | ﹤0.01% |
253,957
+8,796
| +4% | +$60.6K |
|
2693
Limoneira
LMNR
$238M
| $1.79M | ﹤0.01% |
102,499
+2,015
| +2% | +$33.3K |
|
|
PAND
2694
DELISTED
Pandion Therapeutics Inc. Common Stock
PAND
| $1.77M | ﹤0.01% |
29,532
+14,092
| +91% | +$510K |
|
2695
Comstock Resources
CRK
$3.95B
| $1.73M | ﹤0.01% |
312,810
-812
| -0.3% | -$4.36K |
|
|
KC
2696
Kingsoft Cloud Holdings
KC
$3.58B
| $1.73M | ﹤0.01% |
43,888
+1,500
| +4% | +$79.6K |
|
2697
Alpha and Omega Semiconductor
AOSL
$947M
| $1.72M | ﹤0.01% |
52,703
+3,049
| +6% | +$100K |
|
|
SCPL
2698
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
| $1.72M | ﹤0.01% |
106,258
+5,361
| +5% | +$92.4K |
|
|
GHL
2699
DELISTED
Greenhill & Co., Inc.
GHL
| $1.69M | ﹤0.01% |
102,723
-193,850
| -65% | -$2.86M |
|
|
AXDX
2700
DELISTED
Accelerate Diagnostics
AXDX
| $1.69M | ﹤0.01% |
20,300
+140
| +0.7% | +$14.2K |
|
Similar funds
Charles Schwab's Q1 2021 Portfolio in Review
As of Q1 2021, Charles Schwab held 3,565 positions worth $273B, up 8.3% from $252B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Charles Schwab's Q1 2021 filing shows 168 new, 2,233 increased, 898 reduced and 80 closed positions. Its largest new stake was State Street Financial Select Sector SPDR ETF: 6,984,918 shares worth $238M. The largest sale was ExxonMobil, an estimated $776M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q1 2021 buy was State Street Financial Select Sector SPDR ETF: 6,984,918 shares worth $238M.
- Charles Schwab added most to Broadcom in Q1 2021, an estimated $892M increase.
- Charles Schwab's biggest Q1 2021 reduction was ExxonMobil, cutting an estimated $776M.
- Charles Schwab fully exited Invesco QQQ Trust in Q1 2021, selling an estimated $396M.
- Charles Schwab's ten largest holdings make up 16% of its $273B portfolio in Q1 2021.
- Charles Schwab opened 168 new positions and closed 80 in Q1 2021.
- Charles Schwab's portfolio value rose 8.3% quarter-over-quarter to $273B.
Based on Charles Schwab's 13F filing for Q1 2021, filed 17 May 2021.